Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001193125-17-276877
Filing Date
2017-09-05
Accepted
2017-09-05 17:22:05
Documents
7
Effectiveness Date
2017-09-05

Document Format Files

Seq Description Document Type Size
1 DEFR14A d449670ddefr14a.htm DEFR14A 458854
2 GRAPHIC g449670g51o28.jpg GRAPHIC 6750
3 GRAPHIC g449670g68d40.jpg GRAPHIC 7348
4 GRAPHIC g449670g82l95.jpg GRAPHIC 13033
5 GRAPHIC g449670page004.jpg GRAPHIC 173036
6 GRAPHIC g449670page005.jpg GRAPHIC 177382
7 GRAPHIC g449670page008.jpg GRAPHIC 206085
  Complete submission text file 0001193125-17-276877.txt   1264146
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: DEFR14A | Act: 34 | File No.: 000-17988 | Film No.: 171069597
SIC: 2835 In Vitro & In Vivo Diagnostic Substances